OTTAWA, Ontario--(BUSINESS WIRE)--BIOTECanada applauds the Federal Government's budget for its continued commitment to fiscal responsibility and maintaining Canada's global economic competitiveness and welcomes the measures contained in the federal budget to stimulate investment in innovation, research and development in Canada's biotech sector.
“The measures and commitments contained in the Economic Action Plan 2013 signals the Government remains committed to supporting innovation in life sciences,” commented Andrew Casey, President and CEO of BIOTECanada. “In particular, given the continuing global economic uncertainty and the imperative of maintaining Canada's strong macro-fiscal position, the industry greatly appreciates the government's continued funding for key organizations and programs central to supporting research and development in the biotech sector.”
BIOTECanada's members represent a broad range of companies in the biotech sector including health, life sciences, agriculture and manufacturing. Programs and organizations such as Sustainable Development Technology Canada, Genome Canada, Canadian Institute for Health Research, and Centres of Excellence of Canada have proven to be instrumental in stimulating and supporting investment in Canada's biotech sector. In this context, the budget’s measures to re-commit funding for these programs and organizations are greatly appreciated by the industry.
“We look forward to working with like minded organizations such as Sustainable Development Technology Canada, the Canadian Institutes of Health Research, and Genome Canada. With new funding these groups will be able to make smart investments to help Canadian biotech companies grow their businesses and seek new opportunities here at home,” Casey concluded.
BIOTECanada is the national industry association representing nearly 250 biotechnology member companies nation wide, reflecting the diverse nature of Canada’s health, industrial and agricultural biotechnology sectors.